nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—PNP—Cladribine—hematologic cancer	0.159	0.342	CbGbCtD
Didanosine—Entecavir—Cladribine—hematologic cancer	0.131	0.36	CrCrCtD
Didanosine—Zalcitabine—Cytarabine—hematologic cancer	0.116	0.32	CrCrCtD
Didanosine—Zalcitabine—Gemcitabine—hematologic cancer	0.116	0.32	CrCrCtD
Didanosine—SLC29A2—Mercaptopurine—hematologic cancer	0.0708	0.153	CbGbCtD
Didanosine—SLC29A1—Fludarabine—hematologic cancer	0.0679	0.146	CbGbCtD
Didanosine—SLC29A2—Gemcitabine—hematologic cancer	0.0491	0.106	CbGbCtD
Didanosine—SLC29A1—Cytarabine—hematologic cancer	0.0463	0.0999	CbGbCtD
Didanosine—SLC29A1—Mercaptopurine—hematologic cancer	0.0407	0.0877	CbGbCtD
Didanosine—SLC29A1—Gemcitabine—hematologic cancer	0.0282	0.0608	CbGbCtD
Didanosine—PNP—Purine salvage—DCK—hematologic cancer	0.00511	0.164	CbGpPWpGaD
Didanosine—PNP—hematopoietic system—hematologic cancer	0.00336	0.186	CbGeAlD
Didanosine—PNP—Purine metabolism—GMPS—hematologic cancer	0.00303	0.0976	CbGpPWpGaD
Didanosine—PNP—Purine metabolism—DCK—hematologic cancer	0.00242	0.078	CbGpPWpGaD
Didanosine—PNP—blood—hematologic cancer	0.00223	0.123	CbGeAlD
Didanosine—PNP—bone marrow—hematologic cancer	0.00215	0.119	CbGeAlD
Didanosine—SLC22A6—Methotrexate—hematologic cancer	0.00212	0.00458	CbGbCtD
Didanosine—PNP—lung—hematologic cancer	0.00195	0.108	CbGeAlD
Didanosine—SLC29A2—blood—hematologic cancer	0.00167	0.0923	CbGeAlD
Didanosine—PNP—Nucleotide metabolism—GMPS—hematologic cancer	0.00152	0.049	CbGpPWpGaD
Didanosine—Zalcitabine—DCK—hematologic cancer	0.0015	1	CrCbGaD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—SLC35B2—hematologic cancer	0.00132	0.0426	CbGpPWpGaD
Didanosine—SLC29A1—hematopoietic system—hematologic cancer	0.00125	0.0691	CbGeAlD
Didanosine—PNP—Nucleotide metabolism—DCK—hematologic cancer	0.00122	0.0392	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—CDA—hematologic cancer	0.0011	0.0355	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—CDA—hematologic cancer	0.00106	0.034	CbGpPWpGaD
Didanosine—SLC29A2—lymph node—hematologic cancer	0.001	0.0554	CbGeAlD
Didanosine—SLC29A1—gonad—hematologic cancer	0.000951	0.0525	CbGeAlD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—SLC35B2—hematologic cancer	0.000917	0.0295	CbGpPWpGaD
Didanosine—SLC29A1—blood—hematologic cancer	0.000829	0.0458	CbGeAlD
Didanosine—SLC29A1—bone marrow—hematologic cancer	0.000802	0.0443	CbGeAlD
Didanosine—SLC29A1—lung—hematologic cancer	0.000727	0.0401	CbGeAlD
Didanosine—SLC29A1—testis—hematologic cancer	0.000686	0.0379	CbGeAlD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ABCC3—hematologic cancer	0.000661	0.0213	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—TXN—hematologic cancer	0.000633	0.0204	CbGpPWpGaD
Didanosine—PNP—Ponatinib—Nilotinib—hematologic cancer	0.000612	0.264	CbGdCrCtD
Didanosine—SLC29A1—Fluoropyrimidine Activity—ABCG2—hematologic cancer	0.000539	0.0174	CbGpPWpGaD
Didanosine—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A1—hematologic cancer	0.000509	0.0164	CbGpPWpGaD
Didanosine—SLC29A1—lymph node—hematologic cancer	0.000497	0.0274	CbGeAlD
Didanosine—PNP—Ponatinib—Imatinib—hematologic cancer	0.000464	0.2	CbGdCrCtD
Didanosine—SLC29A1—Fluoropyrimidine Activity—SMUG1—hematologic cancer	0.000413	0.0133	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—MTHFR—hematologic cancer	0.000289	0.00929	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000284	0.00914	CbGpPWpGaD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—hematologic cancer	0.000271	0.00873	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000253	0.00815	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Idarubicin—hematologic cancer	0.000225	0.0972	CbGdCrCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000205	0.00659	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	0.000197	0.00634	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.00019	0.00613	CbGpPWpGaD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—hematologic cancer	0.000188	0.00605	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	0.000175	0.00565	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000167	0.00539	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000158	0.00508	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000155	0.005	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000152	0.0049	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.000144	0.00465	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—AQP9—hematologic cancer	0.000142	0.00457	CbGpPWpGaD
Didanosine—PNP—Metabolism—FTCD—hematologic cancer	0.000138	0.00446	CbGpPWpGaD
Didanosine—PNP—Metabolism—PHYH—hematologic cancer	0.000138	0.00446	CbGpPWpGaD
Didanosine—PNP—Metabolism—GMPS—hematologic cancer	0.000138	0.00446	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	0.000136	0.00437	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	0.000132	0.00425	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	0.000129	0.00414	CbGpPWpGaD
Didanosine—PNP—Metabolism—SMPD3—hematologic cancer	0.000127	0.00407	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SGK1—hematologic cancer	0.000118	0.00379	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	0.000118	0.00379	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	0.000118	0.00379	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	0.000116	0.00373	CbGpPWpGaD
Didanosine—PNP—Metabolism—ASNS—hematologic cancer	0.000111	0.00356	CbGpPWpGaD
Didanosine—PNP—Metabolism—DCK—hematologic cancer	0.000111	0.00356	CbGpPWpGaD
Didanosine—PNP—Metabolism—B3GAT1—hematologic cancer	0.000111	0.00356	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—TP53—hematologic cancer	0.00011	0.00353	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—NUP98—hematologic cancer	0.000109	0.00352	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—S100A10—hematologic cancer	0.000108	0.00346	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	0.000106	0.00341	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—NUP214—hematologic cancer	0.000106	0.0034	CbGpPWpGaD
Didanosine—PNP—Metabolism—HDC—hematologic cancer	0.000105	0.00338	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Epirubicin—hematologic cancer	0.000103	0.0446	CbGdCrCtD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—hematologic cancer	0.000102	0.00328	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	0.0001	0.00322	CbGpPWpGaD
Didanosine—PNP—Metabolism—CDA—hematologic cancer	9.59e-05	0.00309	CbGpPWpGaD
Didanosine—PNP—Daunorubicin—Doxorubicin—hematologic cancer	9.56e-05	0.0413	CbGdCrCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	9.4e-05	0.00303	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	9.3e-05	0.00299	CbGpPWpGaD
Didanosine—PNP—Metabolism—PC—hematologic cancer	9.23e-05	0.00297	CbGpPWpGaD
Didanosine—PNP—Metabolism—GBA—hematologic cancer	8.92e-05	0.00287	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC35B2—hematologic cancer	8.92e-05	0.00287	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	8.91e-05	0.00287	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	8.5e-05	0.00274	CbGpPWpGaD
Didanosine—PNP—Metabolism—MTAP—hematologic cancer	8.16e-05	0.00263	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SGK1—hematologic cancer	8.15e-05	0.00262	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	8.15e-05	0.00262	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	8.15e-05	0.00262	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NUP98—hematologic cancer	8.03e-05	0.00258	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC35B2—hematologic cancer	7.87e-05	0.00253	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	7.79e-05	0.00251	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NUP214—hematologic cancer	7.74e-05	0.00249	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	7.58e-05	0.00244	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	7.34e-05	0.00236	CbGpPWpGaD
Didanosine—PNP—Metabolism—FHL2—hematologic cancer	7.27e-05	0.00234	CbGpPWpGaD
Didanosine—PNP—Metabolism—AGRN—hematologic cancer	7.13e-05	0.0023	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC26A4—hematologic cancer	7.01e-05	0.00226	CbGpPWpGaD
Didanosine—PNP—Metabolism—IDH2—hematologic cancer	6.76e-05	0.00218	CbGpPWpGaD
Didanosine—PNP—Metabolism—HMMR—hematologic cancer	6.76e-05	0.00218	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TFRC—hematologic cancer	6.76e-05	0.00217	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	6.44e-05	0.00207	CbGpPWpGaD
Didanosine—PNP—Metabolism—ARNTL—hematologic cancer	6.35e-05	0.00205	CbGpPWpGaD
Didanosine—PNP—Metabolism—CA9—hematologic cancer	6.18e-05	0.00199	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACP5—hematologic cancer	6.18e-05	0.00199	CbGpPWpGaD
Didanosine—PNP—Metabolism—NCOR2—hematologic cancer	6.1e-05	0.00196	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	5.89e-05	0.0019	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	5.82e-05	0.00187	CbGpPWpGaD
Didanosine—PNP—Metabolism—IDH1—hematologic cancer	5.81e-05	0.00187	CbGpPWpGaD
Didanosine—PNP—Metabolism—ABCC3—hematologic cancer	5.75e-05	0.00185	CbGpPWpGaD
Didanosine—PNP—Metabolism—TXN—hematologic cancer	5.75e-05	0.00185	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTO1—hematologic cancer	5.75e-05	0.00185	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—AQP9—hematologic cancer	5.67e-05	0.00183	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	5.67e-05	0.00183	CbGpPWpGaD
Didanosine—PNP—Metabolism—SPHK1—hematologic cancer	5.62e-05	0.00181	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NUP98—hematologic cancer	5.56e-05	0.00179	CbGpPWpGaD
Didanosine—PNP—Metabolism—UGT1A1—hematologic cancer	5.4e-05	0.00174	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.4e-05	0.00174	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.36e-05	0.00173	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—FXYD6—hematologic cancer	5.27e-05	0.0017	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC22A1—hematologic cancer	5.26e-05	0.00169	CbGpPWpGaD
Didanosine—PNP—Metabolism—CRABP1—hematologic cancer	5.26e-05	0.00169	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.25e-05	0.00169	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALOX5—hematologic cancer	5.12e-05	0.00165	CbGpPWpGaD
Didanosine—PNP—Metabolism—NUP98—hematologic cancer	4.96e-05	0.0016	CbGpPWpGaD
Didanosine—PNP—Clobetasol propionate—Dexamethasone—hematologic cancer	4.92e-05	0.0212	CbGdCrCtD
Didanosine—PNP—Clobetasol propionate—Betamethasone—hematologic cancer	4.92e-05	0.0212	CbGdCrCtD
Didanosine—PNP—Flunisolide—Dexamethasone—hematologic cancer	4.86e-05	0.021	CbGdCrCtD
Didanosine—PNP—Flunisolide—Betamethasone—hematologic cancer	4.86e-05	0.021	CbGdCrCtD
Didanosine—PNP—Metabolism—ADCY7—hematologic cancer	4.82e-05	0.00155	CbGpPWpGaD
Didanosine—PNP—Metabolism—NCOA3—hematologic cancer	4.82e-05	0.00155	CbGpPWpGaD
Didanosine—PNP—Clobetasol propionate—Triamcinolone—hematologic cancer	4.81e-05	0.0208	CbGdCrCtD
Didanosine—PNP—Metabolism—NUP214—hematologic cancer	4.78e-05	0.00154	CbGpPWpGaD
Didanosine—PNP—Flunisolide—Triamcinolone—hematologic cancer	4.75e-05	0.0205	CbGdCrCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	4.73e-05	0.00152	CbGpPWpGaD
Didanosine—PNP—Fluticasone Propionate—Betamethasone—hematologic cancer	4.69e-05	0.0202	CbGdCrCtD
Didanosine—PNP—Fluticasone Propionate—Dexamethasone—hematologic cancer	4.69e-05	0.0202	CbGdCrCtD
Didanosine—PNP—Metabolism—ABCG2—hematologic cancer	4.68e-05	0.00151	CbGpPWpGaD
Didanosine—PNP—Metabolism—MTR—hematologic cancer	4.68e-05	0.00151	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	4.68e-05	0.00151	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—hematologic cancer	4.64e-05	0.00149	CbGpPWpGaD
Didanosine—PNP—Metabolism—ENO2—hematologic cancer	4.59e-05	0.00148	CbGpPWpGaD
Didanosine—PNP—Fluticasone Propionate—Triamcinolone—hematologic cancer	4.58e-05	0.0198	CbGdCrCtD
Didanosine—PNP—Clobetasol propionate—Prednisone—hematologic cancer	4.56e-05	0.0197	CbGdCrCtD
Didanosine—PNP—Flunisolide—Prednisone—hematologic cancer	4.5e-05	0.0194	CbGdCrCtD
Didanosine—PNP—Metabolism—GSTT1—hematologic cancer	4.46e-05	0.00143	CbGpPWpGaD
Didanosine—PNP—Clobetasol propionate—Prednisolone—hematologic cancer	4.45e-05	0.0192	CbGdCrCtD
Didanosine—PNP—Fluocinolone Acetonide—Betamethasone—hematologic cancer	4.42e-05	0.0191	CbGdCrCtD
Didanosine—PNP—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	4.42e-05	0.0191	CbGdCrCtD
Didanosine—PNP—Flunisolide—Prednisolone—hematologic cancer	4.4e-05	0.019	CbGdCrCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—NUP98—hematologic cancer	4.38e-05	0.00141	CbGpPWpGaD
Didanosine—PNP—Metabolism—SDC1—hematologic cancer	4.35e-05	0.0014	CbGpPWpGaD
Didanosine—PNP—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	4.32e-05	0.0186	CbGdCrCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—S100A10—hematologic cancer	4.3e-05	0.00138	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—NUP214—hematologic cancer	4.22e-05	0.00136	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.04e-05	0.0013	CbGpPWpGaD
Didanosine—PNP—Fluocinolone Acetonide—Prednisolone—hematologic cancer	4e-05	0.0173	CbGdCrCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	4e-05	0.00129	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	3.93e-05	0.00127	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.76e-05	0.00121	CbGpPWpGaD
Didanosine—PNP—Metabolism—CD44—hematologic cancer	3.7e-05	0.00119	CbGpPWpGaD
Didanosine—PNP—Metabolism—NQO1—hematologic cancer	3.7e-05	0.00119	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.56e-05	0.00115	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYCS—hematologic cancer	3.5e-05	0.00113	CbGpPWpGaD
Didanosine—PNP—Metabolism—HSP90AA1—hematologic cancer	3.48e-05	0.00112	CbGpPWpGaD
Didanosine—PNP—Danazol—Prednisone—hematologic cancer	3.45e-05	0.0149	CbGdCrCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.28e-05	0.00106	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.26e-05	0.00105	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.26e-05	0.00105	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.26e-05	0.00105	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.16e-05	0.00102	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTP1—hematologic cancer	3.09e-05	0.000994	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.96e-05	0.000953	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.93e-05	0.000945	CbGpPWpGaD
Didanosine—PNP—Metabolism—ABCB1—hematologic cancer	2.92e-05	0.000941	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTM1—hematologic cancer	2.84e-05	0.000914	CbGpPWpGaD
Didanosine—PNP—Metabolism—NCOR1—hematologic cancer	2.84e-05	0.000914	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.58e-05	0.000829	CbGpPWpGaD
Didanosine—PNP—Metabolism—MTHFR—hematologic cancer	2.51e-05	0.000807	CbGpPWpGaD
Didanosine—Discomfort—Betamethasone—hematologic cancer	2.4e-05	0.000198	CcSEcCtD
Didanosine—Discomfort—Dexamethasone—hematologic cancer	2.4e-05	0.000198	CcSEcCtD
Didanosine—Dermatitis—Thalidomide—hematologic cancer	2.4e-05	0.000198	CcSEcCtD
Didanosine—Diarrhoea—Vincristine—hematologic cancer	2.39e-05	0.000197	CcSEcCtD
Didanosine—Headache—Thalidomide—hematologic cancer	2.38e-05	0.000197	CcSEcCtD
Didanosine—Pain—Prednisolone—hematologic cancer	2.38e-05	0.000197	CcSEcCtD
Didanosine—Hepatitis—Methotrexate—hematologic cancer	2.38e-05	0.000197	CcSEcCtD
Didanosine—Asthenia—Gemcitabine—hematologic cancer	2.37e-05	0.000196	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.36e-05	0.000759	CbGpPWpGaD
Didanosine—Hepatobiliary disease—Epirubicin—hematologic cancer	2.35e-05	0.000194	CcSEcCtD
Didanosine—Pruritus—Gemcitabine—hematologic cancer	2.34e-05	0.000193	CcSEcCtD
Didanosine—Nausea—Thiotepa—hematologic cancer	2.34e-05	0.000193	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	2.34e-05	0.000193	CcSEcCtD
Didanosine—Anaphylactic shock—Dexamethasone—hematologic cancer	2.33e-05	0.000192	CcSEcCtD
Didanosine—Anaphylactic shock—Betamethasone—hematologic cancer	2.33e-05	0.000192	CcSEcCtD
Didanosine—Hyperglycaemia—Doxorubicin—hematologic cancer	2.32e-05	0.000192	CcSEcCtD
Didanosine—Diarrhoea—Irinotecan—hematologic cancer	2.32e-05	0.000192	CcSEcCtD
Didanosine—Diarrhoea—Mitoxantrone—hematologic cancer	2.32e-05	0.000192	CcSEcCtD
Didanosine—Vomiting—Carmustine—hematologic cancer	2.32e-05	0.000192	CcSEcCtD
Didanosine—Agranulocytosis—Epirubicin—hematologic cancer	2.32e-05	0.000191	CcSEcCtD
Didanosine—Gastrointestinal pain—Etoposide—hematologic cancer	2.31e-05	0.000191	CcSEcCtD
Didanosine—Infection—Betamethasone—hematologic cancer	2.31e-05	0.000191	CcSEcCtD
Didanosine—Infection—Dexamethasone—hematologic cancer	2.31e-05	0.000191	CcSEcCtD
Didanosine—Rash—Carmustine—hematologic cancer	2.3e-05	0.00019	CcSEcCtD
Didanosine—Dermatitis—Carmustine—hematologic cancer	2.3e-05	0.00019	CcSEcCtD
Didanosine—Vomiting—Alitretinoin—hematologic cancer	2.3e-05	0.00019	CcSEcCtD
Didanosine—Paraesthesia—Triamcinolone—hematologic cancer	2.3e-05	0.00019	CcSEcCtD
Didanosine—Anaemia—Prednisone—hematologic cancer	2.29e-05	0.000189	CcSEcCtD
Didanosine—Headache—Carmustine—hematologic cancer	2.29e-05	0.000189	CcSEcCtD
Didanosine—Rash—Alitretinoin—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Didanosine—Dermatitis—Alitretinoin—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Didanosine—Thrombocytopenia—Betamethasone—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Didanosine—Thrombocytopenia—Dexamethasone—hematologic cancer	2.28e-05	0.000188	CcSEcCtD
Didanosine—Vomiting—Ifosfamide—hematologic cancer	2.27e-05	0.000188	CcSEcCtD
Didanosine—Hypersensitivity—Cisplatin—hematologic cancer	2.27e-05	0.000188	CcSEcCtD
Didanosine—Headache—Alitretinoin—hematologic cancer	2.27e-05	0.000187	CcSEcCtD
Didanosine—Diarrhoea—Gemcitabine—hematologic cancer	2.26e-05	0.000187	CcSEcCtD
Didanosine—Nausea—Thalidomide—hematologic cancer	2.26e-05	0.000187	CcSEcCtD
Didanosine—Dyspepsia—Triamcinolone—hematologic cancer	2.26e-05	0.000186	CcSEcCtD
Didanosine—Rash—Ifosfamide—hematologic cancer	2.26e-05	0.000186	CcSEcCtD
Didanosine—Dermatitis—Ifosfamide—hematologic cancer	2.25e-05	0.000186	CcSEcCtD
Didanosine—Neuropathy peripheral—Doxorubicin—hematologic cancer	2.25e-05	0.000186	CcSEcCtD
Didanosine—Malaise—Prednisone—hematologic cancer	2.24e-05	0.000185	CcSEcCtD
Didanosine—Abdominal pain—Etoposide—hematologic cancer	2.23e-05	0.000184	CcSEcCtD
Didanosine—Body temperature increased—Etoposide—hematologic cancer	2.23e-05	0.000184	CcSEcCtD
Didanosine—Hepatitis—Epirubicin—hematologic cancer	2.23e-05	0.000184	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.22e-05	0.000716	CbGpPWpGaD
Didanosine—Hypoaesthesia—Epirubicin—hematologic cancer	2.22e-05	0.000183	CcSEcCtD
Didanosine—Vomiting—Vincristine—hematologic cancer	2.22e-05	0.000183	CcSEcCtD
Didanosine—Anorexia—Betamethasone—hematologic cancer	2.22e-05	0.000183	CcSEcCtD
Didanosine—Anorexia—Dexamethasone—hematologic cancer	2.22e-05	0.000183	CcSEcCtD
Didanosine—Asthenia—Cisplatin—hematologic cancer	2.21e-05	0.000183	CcSEcCtD
Didanosine—Rash—Vincristine—hematologic cancer	2.2e-05	0.000182	CcSEcCtD
Didanosine—Dermatitis—Vincristine—hematologic cancer	2.2e-05	0.000181	CcSEcCtD
Didanosine—Pain—Triamcinolone—hematologic cancer	2.19e-05	0.000181	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.19e-05	0.000705	CbGpPWpGaD
Didanosine—Headache—Vincristine—hematologic cancer	2.19e-05	0.00018	CcSEcCtD
Didanosine—Hepatobiliary disease—Doxorubicin—hematologic cancer	2.17e-05	0.000179	CcSEcCtD
Didanosine—Nausea—Carmustine—hematologic cancer	2.17e-05	0.000179	CcSEcCtD
Didanosine—Vomiting—Mitoxantrone—hematologic cancer	2.16e-05	0.000178	CcSEcCtD
Didanosine—Vomiting—Irinotecan—hematologic cancer	2.16e-05	0.000178	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.16e-05	0.000695	CbGpPWpGaD
Didanosine—Nausea—Alitretinoin—hematologic cancer	2.15e-05	0.000178	CcSEcCtD
Didanosine—Agranulocytosis—Doxorubicin—hematologic cancer	2.14e-05	0.000177	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.14e-05	0.00069	CbGpPWpGaD
Didanosine—Rash—Mitoxantrone—hematologic cancer	2.14e-05	0.000177	CcSEcCtD
Didanosine—Rash—Irinotecan—hematologic cancer	2.14e-05	0.000177	CcSEcCtD
Didanosine—Dermatitis—Mitoxantrone—hematologic cancer	2.14e-05	0.000177	CcSEcCtD
Didanosine—Dermatitis—Irinotecan—hematologic cancer	2.14e-05	0.000177	CcSEcCtD
Didanosine—Chills—Methotrexate—hematologic cancer	2.14e-05	0.000176	CcSEcCtD
Didanosine—Headache—Mitoxantrone—hematologic cancer	2.13e-05	0.000176	CcSEcCtD
Didanosine—Headache—Irinotecan—hematologic cancer	2.13e-05	0.000176	CcSEcCtD
Didanosine—Nausea—Ifosfamide—hematologic cancer	2.13e-05	0.000175	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.12e-05	0.000175	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.12e-05	0.000175	CcSEcCtD
Didanosine—Arthralgia—Prednisone—hematologic cancer	2.11e-05	0.000174	CcSEcCtD
Didanosine—Myalgia—Prednisone—hematologic cancer	2.11e-05	0.000174	CcSEcCtD
Didanosine—Diarrhoea—Cisplatin—hematologic cancer	2.11e-05	0.000174	CcSEcCtD
Didanosine—PNP—Metabolism—PIK3CG—hematologic cancer	2.11e-05	0.000678	CbGpPWpGaD
Didanosine—Alopecia—Methotrexate—hematologic cancer	2.11e-05	0.000174	CcSEcCtD
Didanosine—Vomiting—Gemcitabine—hematologic cancer	2.1e-05	0.000174	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.1e-05	0.000676	CbGpPWpGaD
Didanosine—Paraesthesia—Dexamethasone—hematologic cancer	2.09e-05	0.000172	CcSEcCtD
Didanosine—Paraesthesia—Betamethasone—hematologic cancer	2.09e-05	0.000172	CcSEcCtD
Didanosine—Discomfort—Prednisone—hematologic cancer	2.09e-05	0.000172	CcSEcCtD
Didanosine—Rash—Gemcitabine—hematologic cancer	2.09e-05	0.000172	CcSEcCtD
Didanosine—Dermatitis—Gemcitabine—hematologic cancer	2.08e-05	0.000172	CcSEcCtD
Didanosine—Hypersensitivity—Etoposide—hematologic cancer	2.08e-05	0.000172	CcSEcCtD
Didanosine—Headache—Gemcitabine—hematologic cancer	2.07e-05	0.000171	CcSEcCtD
Didanosine—Nausea—Vincristine—hematologic cancer	2.07e-05	0.000171	CcSEcCtD
Didanosine—Hepatitis—Doxorubicin—hematologic cancer	2.06e-05	0.00017	CcSEcCtD
Didanosine—Hypersensitivity—Prednisolone—hematologic cancer	2.05e-05	0.00017	CcSEcCtD
Didanosine—Hypoaesthesia—Doxorubicin—hematologic cancer	2.05e-05	0.000169	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.05e-05	0.00066	CbGpPWpGaD
Didanosine—Dyspepsia—Betamethasone—hematologic cancer	2.05e-05	0.000169	CcSEcCtD
Didanosine—Dyspepsia—Dexamethasone—hematologic cancer	2.05e-05	0.000169	CcSEcCtD
Didanosine—Asthenia—Etoposide—hematologic cancer	2.03e-05	0.000167	CcSEcCtD
Didanosine—Body temperature increased—Triamcinolone—hematologic cancer	2.03e-05	0.000167	CcSEcCtD
Didanosine—Anaphylactic shock—Prednisone—hematologic cancer	2.03e-05	0.000167	CcSEcCtD
Didanosine—Decreased appetite—Betamethasone—hematologic cancer	2.02e-05	0.000167	CcSEcCtD
Didanosine—Decreased appetite—Dexamethasone—hematologic cancer	2.02e-05	0.000167	CcSEcCtD
Didanosine—Nausea—Irinotecan—hematologic cancer	2.02e-05	0.000167	CcSEcCtD
Didanosine—Nausea—Mitoxantrone—hematologic cancer	2.02e-05	0.000167	CcSEcCtD
Didanosine—Infection—Prednisone—hematologic cancer	2.01e-05	0.000166	CcSEcCtD
Didanosine—Chills—Epirubicin—hematologic cancer	2e-05	0.000165	CcSEcCtD
Didanosine—Pruritus—Etoposide—hematologic cancer	2e-05	0.000165	CcSEcCtD
Didanosine—Pain—Dexamethasone—hematologic cancer	1.99e-05	0.000164	CcSEcCtD
Didanosine—Pain—Betamethasone—hematologic cancer	1.99e-05	0.000164	CcSEcCtD
Didanosine—Alopecia—Epirubicin—hematologic cancer	1.97e-05	0.000163	CcSEcCtD
Didanosine—Nausea—Gemcitabine—hematologic cancer	1.97e-05	0.000162	CcSEcCtD
Didanosine—Vomiting—Cisplatin—hematologic cancer	1.96e-05	0.000162	CcSEcCtD
Didanosine—PNP—Metabolism—CREBBP—hematologic cancer	1.95e-05	0.000629	CbGpPWpGaD
Didanosine—Rash—Cisplatin—hematologic cancer	1.94e-05	0.000161	CcSEcCtD
Didanosine—Dermatitis—Cisplatin—hematologic cancer	1.94e-05	0.00016	CcSEcCtD
Didanosine—Diarrhoea—Etoposide—hematologic cancer	1.93e-05	0.00016	CcSEcCtD
Didanosine—Anorexia—Prednisone—hematologic cancer	1.93e-05	0.000159	CcSEcCtD
Didanosine—Anaemia—Methotrexate—hematologic cancer	1.92e-05	0.000158	CcSEcCtD
Didanosine—Flatulence—Epirubicin—hematologic cancer	1.91e-05	0.000158	CcSEcCtD
Didanosine—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.9e-05	0.000157	CcSEcCtD
Didanosine—Gastrointestinal pain—Betamethasone—hematologic cancer	1.9e-05	0.000157	CcSEcCtD
Didanosine—Hypersensitivity—Triamcinolone—hematologic cancer	1.89e-05	0.000156	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.87e-05	0.000603	CbGpPWpGaD
Didanosine—Malaise—Methotrexate—hematologic cancer	1.87e-05	0.000154	CcSEcCtD
Didanosine—Leukopenia—Methotrexate—hematologic cancer	1.86e-05	0.000153	CcSEcCtD
Didanosine—PNP—Metabolism—PIK3CD—hematologic cancer	1.85e-05	0.000596	CbGpPWpGaD
Didanosine—Chills—Doxorubicin—hematologic cancer	1.85e-05	0.000153	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.85e-05	0.000152	CcSEcCtD
Didanosine—Asthenia—Triamcinolone—hematologic cancer	1.84e-05	0.000152	CcSEcCtD
Didanosine—Body temperature increased—Betamethasone—hematologic cancer	1.84e-05	0.000152	CcSEcCtD
Didanosine—Body temperature increased—Dexamethasone—hematologic cancer	1.84e-05	0.000152	CcSEcCtD
Didanosine—Abdominal pain—Betamethasone—hematologic cancer	1.84e-05	0.000152	CcSEcCtD
Didanosine—Abdominal pain—Dexamethasone—hematologic cancer	1.84e-05	0.000152	CcSEcCtD
Didanosine—Nausea—Cisplatin—hematologic cancer	1.83e-05	0.000151	CcSEcCtD
Didanosine—PNP—Metabolism—ALB—hematologic cancer	1.83e-05	0.000589	CbGpPWpGaD
Didanosine—Alopecia—Doxorubicin—hematologic cancer	1.82e-05	0.00015	CcSEcCtD
Didanosine—Paraesthesia—Prednisone—hematologic cancer	1.82e-05	0.00015	CcSEcCtD
Didanosine—Pruritus—Triamcinolone—hematologic cancer	1.81e-05	0.00015	CcSEcCtD
Didanosine—Vomiting—Etoposide—hematologic cancer	1.8e-05	0.000148	CcSEcCtD
Didanosine—Anaemia—Epirubicin—hematologic cancer	1.79e-05	0.000148	CcSEcCtD
Didanosine—Dyspepsia—Prednisone—hematologic cancer	1.78e-05	0.000147	CcSEcCtD
Didanosine—Rash—Etoposide—hematologic cancer	1.78e-05	0.000147	CcSEcCtD
Didanosine—Dermatitis—Etoposide—hematologic cancer	1.78e-05	0.000147	CcSEcCtD
Didanosine—Headache—Etoposide—hematologic cancer	1.77e-05	0.000146	CcSEcCtD
Didanosine—Flatulence—Doxorubicin—hematologic cancer	1.77e-05	0.000146	CcSEcCtD
Didanosine—Arthralgia—Methotrexate—hematologic cancer	1.77e-05	0.000146	CcSEcCtD
Didanosine—Myalgia—Methotrexate—hematologic cancer	1.77e-05	0.000146	CcSEcCtD
Didanosine—Decreased appetite—Prednisone—hematologic cancer	1.76e-05	0.000145	CcSEcCtD
Didanosine—Rash—Prednisolone—hematologic cancer	1.76e-05	0.000145	CcSEcCtD
Didanosine—Dermatitis—Prednisolone—hematologic cancer	1.76e-05	0.000145	CcSEcCtD
Didanosine—Malaise—Epirubicin—hematologic cancer	1.75e-05	0.000144	CcSEcCtD
Didanosine—PNP—Metabolism—PIK3R1—hematologic cancer	1.75e-05	0.000563	CbGpPWpGaD
Didanosine—Headache—Prednisolone—hematologic cancer	1.75e-05	0.000144	CcSEcCtD
Didanosine—Discomfort—Methotrexate—hematologic cancer	1.74e-05	0.000144	CcSEcCtD
Didanosine—Leukopenia—Epirubicin—hematologic cancer	1.74e-05	0.000143	CcSEcCtD
Didanosine—Anaphylactic shock—Methotrexate—hematologic cancer	1.69e-05	0.00014	CcSEcCtD
Didanosine—Infection—Methotrexate—hematologic cancer	1.68e-05	0.000139	CcSEcCtD
Didanosine—Nausea—Etoposide—hematologic cancer	1.68e-05	0.000139	CcSEcCtD
Didanosine—Asthenia—Dexamethasone—hematologic cancer	1.67e-05	0.000138	CcSEcCtD
Didanosine—Asthenia—Betamethasone—hematologic cancer	1.67e-05	0.000138	CcSEcCtD
Didanosine—Anaemia—Doxorubicin—hematologic cancer	1.66e-05	0.000137	CcSEcCtD
Didanosine—Thrombocytopenia—Methotrexate—hematologic cancer	1.66e-05	0.000137	CcSEcCtD
Didanosine—Gastrointestinal pain—Prednisone—hematologic cancer	1.66e-05	0.000137	CcSEcCtD
Didanosine—Nausea—Prednisolone—hematologic cancer	1.66e-05	0.000137	CcSEcCtD
Didanosine—Arthralgia—Epirubicin—hematologic cancer	1.65e-05	0.000136	CcSEcCtD
Didanosine—Myalgia—Epirubicin—hematologic cancer	1.65e-05	0.000136	CcSEcCtD
Didanosine—Pruritus—Dexamethasone—hematologic cancer	1.65e-05	0.000136	CcSEcCtD
Didanosine—Pruritus—Betamethasone—hematologic cancer	1.65e-05	0.000136	CcSEcCtD
Didanosine—Discomfort—Epirubicin—hematologic cancer	1.63e-05	0.000135	CcSEcCtD
Didanosine—Vomiting—Triamcinolone—hematologic cancer	1.63e-05	0.000135	CcSEcCtD
Didanosine—Malaise—Doxorubicin—hematologic cancer	1.62e-05	0.000134	CcSEcCtD
Didanosine—Rash—Triamcinolone—hematologic cancer	1.62e-05	0.000133	CcSEcCtD
Didanosine—Dry mouth—Epirubicin—hematologic cancer	1.62e-05	0.000133	CcSEcCtD
Didanosine—PNP—Metabolism—PIK3CB—hematologic cancer	1.61e-05	0.00052	CbGpPWpGaD
Didanosine—Dermatitis—Triamcinolone—hematologic cancer	1.61e-05	0.000133	CcSEcCtD
Didanosine—Anorexia—Methotrexate—hematologic cancer	1.61e-05	0.000133	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—ALB—hematologic cancer	1.61e-05	0.000519	CbGpPWpGaD
Didanosine—Leukopenia—Doxorubicin—hematologic cancer	1.61e-05	0.000133	CcSEcCtD
Didanosine—Headache—Triamcinolone—hematologic cancer	1.61e-05	0.000133	CcSEcCtD
Didanosine—Abdominal pain—Prednisone—hematologic cancer	1.6e-05	0.000132	CcSEcCtD
Didanosine—Body temperature increased—Prednisone—hematologic cancer	1.6e-05	0.000132	CcSEcCtD
Didanosine—Diarrhoea—Dexamethasone—hematologic cancer	1.59e-05	0.000131	CcSEcCtD
Didanosine—Diarrhoea—Betamethasone—hematologic cancer	1.59e-05	0.000131	CcSEcCtD
Didanosine—Anaphylactic shock—Epirubicin—hematologic cancer	1.58e-05	0.000131	CcSEcCtD
Didanosine—Infection—Epirubicin—hematologic cancer	1.57e-05	0.00013	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.57e-05	0.000506	CbGpPWpGaD
Didanosine—Thrombocytopenia—Epirubicin—hematologic cancer	1.55e-05	0.000128	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.54e-05	0.000127	CcSEcCtD
Didanosine—Arthralgia—Doxorubicin—hematologic cancer	1.53e-05	0.000126	CcSEcCtD
Didanosine—Myalgia—Doxorubicin—hematologic cancer	1.53e-05	0.000126	CcSEcCtD
Didanosine—Nausea—Triamcinolone—hematologic cancer	1.52e-05	0.000126	CcSEcCtD
Didanosine—Paraesthesia—Methotrexate—hematologic cancer	1.52e-05	0.000125	CcSEcCtD
Didanosine—Discomfort—Doxorubicin—hematologic cancer	1.51e-05	0.000125	CcSEcCtD
Didanosine—Anorexia—Epirubicin—hematologic cancer	1.51e-05	0.000125	CcSEcCtD
Didanosine—Dry mouth—Doxorubicin—hematologic cancer	1.5e-05	0.000123	CcSEcCtD
Didanosine—Hypersensitivity—Prednisone—hematologic cancer	1.49e-05	0.000123	CcSEcCtD
Didanosine—Dyspepsia—Methotrexate—hematologic cancer	1.49e-05	0.000123	CcSEcCtD
Didanosine—Vomiting—Dexamethasone—hematologic cancer	1.48e-05	0.000122	CcSEcCtD
Didanosine—Vomiting—Betamethasone—hematologic cancer	1.48e-05	0.000122	CcSEcCtD
Didanosine—Decreased appetite—Methotrexate—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Didanosine—Rash—Dexamethasone—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Didanosine—Rash—Betamethasone—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Didanosine—Anaphylactic shock—Doxorubicin—hematologic cancer	1.47e-05	0.000121	CcSEcCtD
Didanosine—Dermatitis—Dexamethasone—hematologic cancer	1.46e-05	0.000121	CcSEcCtD
Didanosine—Dermatitis—Betamethasone—hematologic cancer	1.46e-05	0.000121	CcSEcCtD
Didanosine—Headache—Dexamethasone—hematologic cancer	1.46e-05	0.00012	CcSEcCtD
Didanosine—Headache—Betamethasone—hematologic cancer	1.46e-05	0.00012	CcSEcCtD
Didanosine—Infection—Doxorubicin—hematologic cancer	1.46e-05	0.00012	CcSEcCtD
Didanosine—Asthenia—Prednisone—hematologic cancer	1.45e-05	0.00012	CcSEcCtD
Didanosine—Pain—Methotrexate—hematologic cancer	1.45e-05	0.000119	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.44e-05	0.000119	CcSEcCtD
Didanosine—Thrombocytopenia—Doxorubicin—hematologic cancer	1.43e-05	0.000118	CcSEcCtD
Didanosine—Pruritus—Prednisone—hematologic cancer	1.43e-05	0.000118	CcSEcCtD
Didanosine—Paraesthesia—Epirubicin—hematologic cancer	1.42e-05	0.000117	CcSEcCtD
Didanosine—Anorexia—Doxorubicin—hematologic cancer	1.4e-05	0.000115	CcSEcCtD
Didanosine—PNP—Metabolism—PTEN—hematologic cancer	1.4e-05	0.000449	CbGpPWpGaD
Didanosine—Dyspepsia—Epirubicin—hematologic cancer	1.39e-05	0.000115	CcSEcCtD
Didanosine—Diarrhoea—Prednisone—hematologic cancer	1.39e-05	0.000114	CcSEcCtD
Didanosine—Gastrointestinal pain—Methotrexate—hematologic cancer	1.38e-05	0.000114	CcSEcCtD
Didanosine—Nausea—Betamethasone—hematologic cancer	1.38e-05	0.000114	CcSEcCtD
Didanosine—Nausea—Dexamethasone—hematologic cancer	1.38e-05	0.000114	CcSEcCtD
Didanosine—Decreased appetite—Epirubicin—hematologic cancer	1.38e-05	0.000114	CcSEcCtD
Didanosine—Pain—Epirubicin—hematologic cancer	1.35e-05	0.000112	CcSEcCtD
Didanosine—Body temperature increased—Methotrexate—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Didanosine—Abdominal pain—Methotrexate—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.34e-05	0.00011	CcSEcCtD
Didanosine—PNP—Metabolism—EP300—hematologic cancer	1.33e-05	0.000428	CbGpPWpGaD
Didanosine—Paraesthesia—Doxorubicin—hematologic cancer	1.32e-05	0.000109	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.31e-05	0.000422	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.3e-05	0.000107	CcSEcCtD
Didanosine—Dyspepsia—Doxorubicin—hematologic cancer	1.29e-05	0.000106	CcSEcCtD
Didanosine—Vomiting—Prednisone—hematologic cancer	1.29e-05	0.000106	CcSEcCtD
Didanosine—Rash—Prednisone—hematologic cancer	1.28e-05	0.000105	CcSEcCtD
Didanosine—Dermatitis—Prednisone—hematologic cancer	1.28e-05	0.000105	CcSEcCtD
Didanosine—Decreased appetite—Doxorubicin—hematologic cancer	1.27e-05	0.000105	CcSEcCtD
Didanosine—Headache—Prednisone—hematologic cancer	1.27e-05	0.000105	CcSEcCtD
Didanosine—Pain—Doxorubicin—hematologic cancer	1.25e-05	0.000103	CcSEcCtD
Didanosine—Body temperature increased—Epirubicin—hematologic cancer	1.25e-05	0.000103	CcSEcCtD
Didanosine—Abdominal pain—Epirubicin—hematologic cancer	1.25e-05	0.000103	CcSEcCtD
Didanosine—Hypersensitivity—Methotrexate—hematologic cancer	1.25e-05	0.000103	CcSEcCtD
Didanosine—Asthenia—Methotrexate—hematologic cancer	1.21e-05	0.0001	CcSEcCtD
Didanosine—Nausea—Prednisone—hematologic cancer	1.2e-05	9.93e-05	CcSEcCtD
Didanosine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.2e-05	9.89e-05	CcSEcCtD
Didanosine—Pruritus—Methotrexate—hematologic cancer	1.2e-05	9.89e-05	CcSEcCtD
Didanosine—Hypersensitivity—Epirubicin—hematologic cancer	1.17e-05	9.63e-05	CcSEcCtD
Didanosine—Abdominal pain—Doxorubicin—hematologic cancer	1.16e-05	9.56e-05	CcSEcCtD
Didanosine—Body temperature increased—Doxorubicin—hematologic cancer	1.16e-05	9.56e-05	CcSEcCtD
Didanosine—Diarrhoea—Methotrexate—hematologic cancer	1.16e-05	9.56e-05	CcSEcCtD
Didanosine—Asthenia—Epirubicin—hematologic cancer	1.14e-05	9.38e-05	CcSEcCtD
Didanosine—Pruritus—Epirubicin—hematologic cancer	1.12e-05	9.25e-05	CcSEcCtD
Didanosine—Diarrhoea—Epirubicin—hematologic cancer	1.08e-05	8.95e-05	CcSEcCtD
Didanosine—Hypersensitivity—Doxorubicin—hematologic cancer	1.08e-05	8.91e-05	CcSEcCtD
Didanosine—Vomiting—Methotrexate—hematologic cancer	1.08e-05	8.88e-05	CcSEcCtD
Didanosine—Rash—Methotrexate—hematologic cancer	1.07e-05	8.81e-05	CcSEcCtD
Didanosine—Dermatitis—Methotrexate—hematologic cancer	1.07e-05	8.8e-05	CcSEcCtD
Didanosine—Headache—Methotrexate—hematologic cancer	1.06e-05	8.75e-05	CcSEcCtD
Didanosine—Asthenia—Doxorubicin—hematologic cancer	1.05e-05	8.68e-05	CcSEcCtD
Didanosine—Pruritus—Doxorubicin—hematologic cancer	1.04e-05	8.56e-05	CcSEcCtD
Didanosine—Vomiting—Epirubicin—hematologic cancer	1.01e-05	8.31e-05	CcSEcCtD
Didanosine—Nausea—Methotrexate—hematologic cancer	1.01e-05	8.3e-05	CcSEcCtD
Didanosine—Diarrhoea—Doxorubicin—hematologic cancer	1e-05	8.28e-05	CcSEcCtD
Didanosine—Rash—Epirubicin—hematologic cancer	9.99e-06	8.24e-05	CcSEcCtD
Didanosine—Dermatitis—Epirubicin—hematologic cancer	9.98e-06	8.24e-05	CcSEcCtD
Didanosine—Headache—Epirubicin—hematologic cancer	9.92e-06	8.19e-05	CcSEcCtD
Didanosine—PNP—Metabolism—PIK3CA—hematologic cancer	9.84e-06	0.000317	CbGpPWpGaD
Didanosine—Nausea—Epirubicin—hematologic cancer	9.41e-06	7.77e-05	CcSEcCtD
Didanosine—Vomiting—Doxorubicin—hematologic cancer	9.32e-06	7.69e-05	CcSEcCtD
Didanosine—Rash—Doxorubicin—hematologic cancer	9.24e-06	7.63e-05	CcSEcCtD
Didanosine—Dermatitis—Doxorubicin—hematologic cancer	9.23e-06	7.62e-05	CcSEcCtD
Didanosine—Headache—Doxorubicin—hematologic cancer	9.18e-06	7.58e-05	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.76e-06	0.000282	CbGpPWpGaD
Didanosine—Nausea—Doxorubicin—hematologic cancer	8.71e-06	7.19e-05	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ALB—hematologic cancer	8.2e-06	0.000264	CbGpPWpGaD
Didanosine—PNP—Metabolism—AKT1—hematologic cancer	8.04e-06	0.000259	CbGpPWpGaD
